Medicine guide

Abilify Maintena 400 mg

As listed in the register: Abilify Maintena 400 mg, Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension in einer Fertigspritze

400 mg ·

  • Prescription only
  • Pain, sleep, mood, epilepsy and the brain
Active substance
Aripiprazolum
Made by
Lundbeck (Schweiz) AG

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

  • Neuroleptikum

From the official label · 2026-09-30 · Swissmedic

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

BulgariaNo exact match for this strength and form

European UnionNo exact match for this strength and form

SpainNo exact match for this strength and form

CanadaNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

Details

Made byLundbeck (Schweiz) AG
Active substanceAripiprazolum
Used inPain, sleep, mood, epilepsy and the brain
Strength400 mg
ClassificationN05AX12 · Pain, sleep, mood, epilepsy and the brain
Dispensing (as stated by the register)Abgabekategorie B
Name in the registerAbilify Maintena 400 mg, Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension in einer Fertigspritze
Packs1 Fertigspritze(n)
Zulassungsnummer65774
Dosisstärke1

Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician

Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.